Which generation of targeted drug is Mobocertinib?

Mobocertinib (Mobocertinib) is a third-generation targeted drug designed to treat a specific type of non-small cell lung cancer (NSCLC), namely EGFR (epidermal growth factor receptor) mutation-positive NSCLC patients.以下是关于莫博赛替尼作为第三代靶向药物的一些详细信息：

1.First-generation EGFR inhibitors: First-generation EGFR inhibitors include erbetinib (erlotinib) and gefitinib (

2.Second-generation EGFRinhibitors: Second-generation EGFR inhibitors such as afatinib (afatinib) have a broader inhibitory effect and can deal with some patients who are resistant to first-generation drugs. However, drug resistance issues remain.

3.Third generation EGFR inhibitors: Mobosetinib is one of the representatives of the third generation EGFR inhibitors. Its design goal is to overcome the resistance problem of previous generation drugs. Mobosetinib has higher selectivity and specifically inhibits EGFR mutations, especially the EGFR T790M mutation, which is often associated with resistance to EGFR inhibitors. Therefore, moboxetinib can effectively inhibit the growth and division of tumor cells, providing a new treatment option, especially for patients who have developed resistance to early-generation drugs.

总之，莫博赛替尼作为第三代EGFRInhibitors represent an important advance in the treatment of EGFR mutation-positive NSCLC, aiming to provide more effective treatment options and help improve patients' survival and quality of life. The development of this drug represents continued innovation and improvement in cancer treatment in the medical field.

Mobotinib is currently on the market in China, but it is not included in medical insurance. Patients need to pay for it in full, so the price is very high. Please consult the local hospital pharmacy for specific prices. Other versions include the Hong Kong version of the original drug Mobotinib, which costs around 7,000 to 8,000 yuan. The generic drug of Mobotinib is mainly a Laotian generic drug. The price is about three to four thousand yuan, which is nearly half cheaper than the original drug. The ingredients of the original drug and the generic drug are the same.